LumiraDx Awarded CE Mark for Its Cardiovascular NT-proBNP Test

UK-based LumiraDx has received a CE mark for its NT-proBNP test to aid in diagnosing congestive heart failure.

B-type natriuretic peptide (BNP) is a hormone produced by the heart, and N-terminal (NT)-pro hormone BNP (NT-proBNP) is a non-active prohormone that is released from the same molecule that produces BNP.

LumiraDx’s NT-proBNP is a rapid immunofluorescence assay for the quantitative measurement of NT-proBNP in whole blood and plasma specimens.

The company expects to begin marketing the test in Europe later this year.